Atlas Antibodies AB has signed an agreement to acquire UK company HistoCyte Laboratories Ltd. HistoCyte Laboratories' portfolio of innovative cell line materials provides control of immunohistochemical assays used in the diagnosis of cancers.
Pharmaceutical company Merck has signed an agreement to become the exclusive multinational distributor of HistoCyte Laboratories’ portfolio of cell line reference products for immunohistochemistry and in situ hybridisation.